Does cisplatin chemotherapy decrease the MDP uptake of normal bone? An experimental study

[1]  Yuh-Min Chen,et al.  A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma. , 2007, Lung cancer.

[2]  Michel Simonet,et al.  High Intra-abdominal Pressure Enhances the Penetration and Antitumor Effect of Intraperitoneal Cisplatin on Experimental Peritoneal Carcinomatosis , 2006, Annals of surgery.

[3]  S. Masuda,et al.  Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. , 2005, Biochemical pharmacology.

[4]  D. Mercer,et al.  Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase-2. , 2005, Surgery.

[5]  J. Tisaire,et al.  Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study. , 2005, European journal of cancer.

[6]  S. Krüger,et al.  Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. , 2005, European urology.

[7]  H. Lipp,et al.  [Platinum compounds: metabolism, toxicity and supportive strategies]. , 2005, Praxis.

[8]  D. Kraemer,et al.  Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model , 2004, Hearing Research.

[9]  T. Boulikas,et al.  Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). , 2004, Oncology reports.

[10]  M. Küçükaydın,et al.  Evaluation of contralateral testicular damage after unilateral testicular torsion by serum inhibin B levels. , 2001, Journal of pediatric surgery.

[11]  B. Line,et al.  Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m. , 1997, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[12]  H. Fukuda,et al.  [Analysis of contributing factors with high renal uptake of 99mTc-MDP after anti-cancer chemotherapy including cisplatin]. , 1996, Kaku igaku. The Japanese journal of nuclear medicine.

[13]  T. Cornelison,et al.  Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. , 1993, Gynecologic oncology.

[14]  S. Okuno,et al.  [A case of esophageal carcinoma with hypercalcemia caused by PTH-rP--the effect of therapy on the bone and calcium metabolism]. , 1992, Nihon Naibunpi Gakkai zasshi.

[15]  R. Bose,et al.  Phosphonato complexes of platinum(II): kinetics of formation and phosphorus-31 NMR characterization studies. , 1990, Journal of inorganic biochemistry.

[16]  S. Hopfer,et al.  Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry. , 1989, Annals of clinical and laboratory science.

[17]  Y. Yamamoto,et al.  [Renal accumulation of technetium-99m-labeled bone imaging agents in patients treated with cisplatin]. , 1989, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[18]  J. Frühling,et al.  Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)? , 1986, Nuclear medicine communications.

[19]  M. Roskopf,et al.  Experimental drug-induced changes in renal function and biodistribution of 99mTc-MDP. , 1983, Investigative radiology.

[20]  J. Bevan,et al.  Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed). , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[22]  J. Raymakers,et al.  The value of local99mTc (Sn)-MDP bone to soft tissue uptake ratio in osteoporosis, before and during fluoride therapy , 2005, European Journal of Nuclear Medicine.

[23]  A. Iavarone,et al.  Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma , 2004, Journal of Neuro-Oncology.

[24]  Ronald S. Adler,et al.  Musculoskeletal system. , 2000, Ultrasound in medicine & biology.

[25]  Michael A. Wilson.  Textbook of nuclear medicine , 1998 .

[26]  G. Rubini,et al.  A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest. , 1992, Nuclear medicine communications.